Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma

This publication has 40 references indexed in Scilit:

• Decreasing IRS-2 expression in pancreatic β-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression
  Molecular and Cellular Endocrinology, 2003
• cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
  Genes & Development, 2003
• Dysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells
  Hepatology, 2002
• Dysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells
  Hepatology, 2002
• Differential Roles of Insulin Receptor Substrates in the Anti-apoptotic Function of Insulin-like Growth Factor-1 and Insulin
  Published by Elsevier ,2002
• Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines
  Oncogene, 2001
• Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
  Oncogene, 2001
• 4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice
  Published by Elsevier ,1995
• Expression of insulin receptor substrate-1 in hepatocytes: an investigation using monoclonal antibodies
  Cancer Letters, 1994
• Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice
  Journal of Hepatology, 1991